Chiara Lorubbio

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer.

Exploring new frontiers: Outcomes and feasibility of a third radiotherapy course in recurrent prostate cancer.

Journal: Tumori

Published: May 27, 2026

Caring for patients, caring for the planet: extreme hypofractionated curative radiotherapy in the Green Era A Pilot study within the MUSA framework.

Caring for patients, caring for the planet: extreme hypofractionated curative radiotherapy in the Green Era A Pilot study within the MUSA framework.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: December 05, 2025

An overlooked opportunity? SBRT + ADT for aggressive prostate cancer in the elderly.

An overlooked opportunity? SBRT + ADT for aggressive prostate cancer in the elderly.

Journal: Clinical and translational radiation oncology

Published: September 24, 2025

Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration.

Metastasis-directed therapy and standard of care versus standard of care for oligometastatic prostate cancer (WOLVERINE): a systematic review and individual patient data meta-analysis from the X-MET collaboration.

Journal: The Lancet. Oncology

Published: August 11, 2025

ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial.

ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial.

Journal: The Lancet. Oncology

Published: September 23, 2024

Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?

Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?

Journal: Tumori

Published: May 10, 2024

Tools to Guide Radiation Oncologists in the Management of DCIS.

Tools to Guide Radiation Oncologists in the Management of DCIS.

Journal: Healthcare (Basel, Switzerland)

Published: February 01, 2024

Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE".

Extreme-hypofractionated RT with concomitant boost to the DIL in PCa: a 5-year update on oncological and patient-reported outcomes for the phase II trial "GIVE ME FIVE".

Journal: World journal of urology

Published: November 02, 2023

Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current Literature.

Oral Surgery and Osteoradionecrosis in Patients Undergoing Head and Neck Radiation Therapy: An Update of the Current Literature.

Journal: Biomedicines

Published: October 27, 2023

Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostate Cancer-A RADIOSA Trial Preliminary Analysis.

Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostate Cancer-A RADIOSA Trial Preliminary Analysis.

Journal: Nutrients

Published: September 30, 2023

Post-operative KEloids iRradiation (POKER): does the surgery/high-dose interventional radiotherapy association make a winning hand?

Post-operative KEloids iRradiation (POKER): does the surgery/high-dose interventional radiotherapy association make a winning hand?

Journal: La Radiologia medica

Published: May 29, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026